Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Stock
Stocks
6990
CNE1000062J1
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 517.00 HKD | +1.08% |
|
+3.77% | +31.82% |
| Market Cap | 107B 124B 15.76B 13.81B 12.82B 11.78B 22.19B 1,520B 22.52B 153B 59.76B 744B 59.15B 57.88B 2,570B | P/E 2026 * |
-613x | P/E 2027 * | 152x |
|---|---|---|---|---|---|
| Enterprise Value | 103B 119B 15.18B 13.3B 12.35B 11.35B 21.38B 1,465B 21.7B 147B 57.58B 717B 56.99B 55.76B 2,476B | EV / Sales 2026 * |
37.5x | EV / Sales 2027 * | 22.2x |
| Free-Float |
55.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
| 1 day | +1.08% | ||
| 1 week | +3.77% | ||
| Current month | +18.52% | ||
| 1 month | +24.34% | ||
| 3 months | +3.30% | ||
| 6 months | +20.40% | ||
| Current year | +31.82% |
| 1 week | 480 |  | 559 |
| 1 month | 388.8 | | 560 |
| Current year | 339.6 | | 560 |
| 1 year | 339.6 | | 581 |
| 3 years | 62 | | 581 |
| 5 years | 60.6 | | 581 |
| 10 years | 60.6 | | 581 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 54 | 01/03/2022 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 43 | 17/08/2022 |
Xiao Ping Jin
CTO | Chief Tech/Sci/R&D Officer | 49 | 06/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ge Xin Liu
CHM | Chairman | 75 | 01/03/2022 |
Jun You Ge
BRD | Director/Board Member | 54 | 25/02/2022 |
Si Chuan Liu
BRD | Director/Board Member | 42 | 22/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/6/26 | Other | Director | -21,723 | 0.0127% | ||
| 30/6/26 | Other | Company | -86,200 | 0.0504% | ||
| 30/6/26 | Other | Director | -21,723 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +3.77% | +36.92% | +593.96% | 15.59B | |
| -0.43% | -1.26% | +52.13% | +85.69% | 55.57B | |
| -0.24% | +1.04% | +55.76% | +58.36% | 54.26B | |
| -0.49% | -0.15% | -17.57% | -14.18% | 23.35B | |
| -1.64% | -3.07% | +3.42% | +420.23% | 23.54B | |
| +0.05% | +1.68% | +38.71% | -4.57% | 20.32B | |
| +3.16% | +0.79% | +37.98% | -29.06% | 17.36B | |
| +0.43% | -1.67% | +166.53% | +299.61% | 14.96B | |
| -1.37% | -0.68% | +24.06% | +177.38% | 14.11B | |
| -0.44% | -1.26% | +73.36% | +164.15% | 12.61B | |
| Average | +0.00% | -0.02% | +47.13% | +175.16% | 25.17B | |
| Weighted average by Cap. | -0.14% | -0.13% | +45.18% | +139.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.74B 3.17B 405M 355M 329M 303M 570M 39.07B 579M 3.92B 1.54B 19.12B 1.52B 1.49B 66.04B | 4.61B 5.34B 681M 597M 554M 509M 960M 65.75B 974M 6.6B 2.58B 32.17B 2.56B 2.5B 111B |
| Net income | -173M -201M -25.61M -22.44M -20.83M -19.14M -36.07M -2.47B -36.6M -248M -97.12M -1.21B -96.12M -94.05M -4.18B | 687M 795M 101M 88.89M 82.52M 75.83M 143M 9.79B 145M 983M 385M 4.79B 381M 373M 16.55B |
| Net Debt | -3.9B -4.52B -576M -505M -469M -431M -811M -55.59B -823M -5.58B -2.18B -27.2B -2.16B -2.12B -93.96B | -4.47B -5.18B -661M -579M -537M -494M -930M -63.75B -944M -6.4B -2.51B -31.19B -2.48B -2.43B -108B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | HK$517.00 | +1.08% | 877,750 |
| 21/07/26 | HK$511.50 | +1.49% | 1,005,352 |
| 20/07/26 | HK$504.00 | +3.62% | 1,057,280 |
| 17/07/26 | HK$486.40 | -6.91% | 1,908,352 |
| 16/07/26 | HK$522.50 | -2.61% | 1,448,320 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6990 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition